{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:50:07Z","timestamp":1790650207355,"version":"4.1.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002738","name":"Assistance Publique - H\u00f4pitaux de Paris","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005736","name":"Universit\u00e9 Paris Diderot","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005736","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003762","name":"Institut Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005413","name":"Universit\u00e9 Paris Descartes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005413","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-LABX-0013"],"award-info":[{"award-number":["ANR-10-LABX-0013"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007492","name":"Fondation Bettencourt Schueller","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hyperserotonemia is the most replicated biochemical abnormality associated with autism spectrum disorders (ASD). However, previous studies of serotonin synthesis, catabolism, and transport have not elucidated the mechanisms underlying this hyperserotonemia. Here we investigated serotonin sulfation by phenol sulfotransferases (PST) in blood samples from 97 individuals with ASD and their first-degree relatives (138 parents and 56 siblings), compared with 106 controls. We report a deficient activity of both PST isoforms (M and P) in platelets from individuals with ASD (35% and 78% of patients, respectively), confirmed in autoptic tissues (9 pineal gland samples from individuals with ASD\u2014an important source of serotonin). Platelet PST-M deficiency was strongly associated with hyperserotonemia in individuals with ASD. We then explore genetic or pharmacologic modulation of PST activities in mice: variations of PST activities were associated with marked variations of blood serotonin, demonstrating the influence of the sulfation pathway on serotonemia. We also conducted in 1645 individuals an extensive study of <jats:italic>SULT1A<\/jats:italic> genes, encoding PST and mapping at highly polymorphic 16p11.2 locus, which did not reveal an association between copy number or single nucleotide variations and PST activity, blood serotonin or the risk of ASD. In contrast, our broader assessment of sulfation metabolism in ASD showed impairments of other sulfation-related markers, including inorganic sulfate, heparan-sulfate, and heparin sulfate-sulfotransferase. Our study proposes for the first time a compelling mechanism for hyperserotonemia, in a context of global impairment of sulfation metabolism in ASD.<\/jats:p>","DOI":"10.1038\/s41398-020-01125-5","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T20:03:40Z","timestamp":1610049820000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Decreased phenol sulfotransferase activities associated with hyperserotonemia in autism spectrum disorders"],"prefix":"10.1038","volume":"11","author":[{"given":"C\u00e9cile","family":"Pagan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Benabou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Leblond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9989-0685","authenticated-orcid":false,"given":"Freddy","family":"Cliquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3418-9425","authenticated-orcid":false,"given":"Alexandre","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Lemi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hany","family":"Goubran-Botros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Delorme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Leboyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Callebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8164-9220","authenticated-orcid":false,"given":"Thomas","family":"Bourgeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4809-1020","authenticated-orcid":false,"given":"Jean-Marie","family":"Launay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"key":"1125_CR1","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1001\/jamapsychiatry.2019.1411","volume":"76","author":"D Bai","year":"2019","unstructured":"Bai, D. et al. Association of genetic and environmental factors with autism in a 5-country cohort. JAMA Psychiatry 76, 1035\u20131043 (2019).","journal-title":"JAMA Psychiatry"},{"key":"1125_CR2","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/dmcn.13717","volume":"60","author":"M Woodbury-Smith","year":"2018","unstructured":"Woodbury-Smith, M. & Scherer, S. W. Progress in the genetics of autism spectrum disorder. Developmental Med. Child Neurol. 60, 445\u2013451 (2018).","journal-title":"Developmental Med. Child Neurol."},{"key":"1125_CR3","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nrn3992","volume":"16","author":"T Bourgeron","year":"2015","unstructured":"Bourgeron, T. From the genetic architecture to synaptic plasticity in autism spectrum disorder. Nat. Rev. Neurosci. 16, 551\u2013563 (2015).","journal-title":"Nat. Rev. Neurosci."},{"key":"1125_CR4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0022-3476(61)80261-8","volume":"58","author":"RJ Schain","year":"1961","unstructured":"Schain, R. J. & Freedman, D. X. Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. J. Pediatrics 58, 315\u2013320 (1961).","journal-title":"J. Pediatrics"},{"key":"1125_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000118465","volume":"20","author":"JM Launay","year":"1988","unstructured":"Launay, J. M. et al. Serotonin metabolism and other biochemical parameters in infantile autism. A controlled study of 22 autistic children. Neuropsychobiology 20, 1\u201311 (1988).","journal-title":"Neuropsychobiology"},{"key":"1125_CR6","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S0006-3223(97)00532-5","volume":"45","author":"M Leboyer","year":"1999","unstructured":"Leboyer, M. et al. Whole blood serotonin and plasma beta-endorphin in autistic probands and their first-degree relatives. Biol. Psychiatry 45, 158\u2013163 (1999).","journal-title":"Biol. Psychiatry"},{"key":"1125_CR7","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/00004583-200404000-00016","volume":"43","author":"EJ Mulder","year":"2004","unstructured":"Mulder, E. J. et al. Platelet serotonin levels in pervasive developmental disorders and mental retardation: diagnostic group differences, within-group distribution, and behavioral correlates. J. Am. Acad. Child Adolesc. Psychiatry 43, 491\u2013499 (2004).","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"1125_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2014.120","volume":"4","author":"C Pagan","year":"2014","unstructured":"Pagan, C. et al. The serotonin-N-acetylserotonin-melatonin pathway as a biomarker for autism spectrum disorders. Transl. Psychiatry 4, e479 (2014).","journal-title":"Transl. Psychiatry"},{"key":"1125_CR9","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.euroneuro.2014.02.004","volume":"24","author":"S Gabriele","year":"2014","unstructured":"Gabriele, S., Sacco, R. & Persico, A. M. Blood serotonin levels in autism spectrum disorder: a systematic review and meta-analysis. Eur. Neuropsychopharmacol. 24, 919\u2013929 (2014).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"1125_CR10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neuroscience.2015.11.010","volume":"321","author":"CL Muller","year":"2016","unstructured":"Muller, C. L., Anacker, A. M. J. & Veenstra-VanderWeele, J. The serotonin system in autism spectrum disorder: from biomarker to animal models. Neuroscience 321, 24\u201341 (2016).","journal-title":"Neuroscience"},{"key":"1125_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/sj.mp.4000923","volume":"7","author":"C Betancur","year":"2002","unstructured":"Betancur, C. et al. Serotonin transporter gene polymorphisms and hyperserotonemia in autistic disorder. Mol. Psychiatry 7, 67\u201371 (2002).","journal-title":"Mol. Psychiatry"},{"key":"1125_CR12","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1034\/j.1399-0004.2003.00115.x","volume":"64","author":"IL Cohen","year":"2003","unstructured":"Cohen, I. L. et al. Association of autism severity with a monoamine oxidase A functional polymorphism. Clin. Genet. 64, 190\u2013197 (2003).","journal-title":"Clin. Genet."},{"key":"1125_CR13","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1086\/432648","volume":"77","author":"JS Sutcliffe","year":"2005","unstructured":"Sutcliffe, J. S. et al. Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors. Am. J. Hum. Genet. 77, 265\u2013279 (2005).","journal-title":"Am. J. Hum. Genet."},{"key":"1125_CR14","unstructured":"Bosin T. R. In Serotonin in Health and Disease (ed Essman W. B.), vol. 1, 181\u2013300 (Spectrum Publishers, New-York, 1978)."},{"key":"1125_CR15","first-page":"2247","volume":"45","author":"GM Tyce","year":"1986","unstructured":"Tyce, G. M. et al. Amine sulfate formation in the central nervous system. Federation Proc. 45, 2247\u20132253 (1986).","journal-title":"Federation Proc."},{"key":"1125_CR16","unstructured":"Da Prada M., Picotti, G. B., Kettler, R. & Launay, J. M. In Platelets: Cellular Response Mechanisms and their Biological Significance (eds Rotman A., Meyer, F. A., Gitler, C. & Silberberg, A.) 277\u2013288 (Raven Press, New-York, 1980)."},{"key":"1125_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/13590840050000861","volume":"10","author":"RH Waring","year":"2000","unstructured":"Waring, R. H. & Klovrza, L. V. Sulphur metabolism in autism. J. Nutr. Environ. Med. 10, 25\u201332 (2000).","journal-title":"J. Nutr. Environ. Med"},{"key":"1125_CR18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1743-7075-8-34","volume":"8","author":"JB Adams","year":"2011","unstructured":"Adams, J. B. et al. Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity. Nutr. Metab. 8, 34 (2011).","journal-title":"Nutr. Metab."},{"key":"1125_CR19","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.bbr.2012.12.062","volume":"243","author":"BL Pearson","year":"2013","unstructured":"Pearson, B. L., Corley, M. J., Vasconcellos, A., Blanchard, D. C. & Blanchard, R. J. Heparan sulfate deficiency in autistic postmortem brain tissue from the subventricular zone of the lateral ventricles. Behav. Brain Res. 243, 138\u2013145 (2013).","journal-title":"Behav. Brain Res."},{"key":"1125_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0027-5107(01)00207-X","volume":"482","author":"H Glatt","year":"2001","unstructured":"Glatt, H. et al. Human cytosolic sulphotransferases: genetics, characteristics, toxicological aspects. Mutat. Res. 482, 27\u201340 (2001).","journal-title":"Mutat. Res."},{"key":"1125_CR21","first-page":"274","volume":"29","author":"W Honma","year":"2001","unstructured":"Honma, W. et al. Enzymatic characterization and interspecies difference of phenol sulfotransferases, ST1A forms. Drug Metab. Dispos. 29, 274\u2013281 (2001).","journal-title":"Drug Metab. Dispos."},{"key":"1125_CR22","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1177\/096032719601500701","volume":"15","author":"MW Coughtrie","year":"1996","unstructured":"Coughtrie, M. W. Sulphation catalysed by the human cytosolic sulphotransferases-chemical defence or molecular terrorism? Hum. Exp. Toxicol. 15, 547\u2013555 (1996).","journal-title":"Hum. Exp. Toxicol."},{"key":"1125_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02152-x","volume":"7","author":"C Pagan","year":"2017","unstructured":"Pagan, C. et al. Disruption of melatonin synthesis is associated with impaired 14-3-3 and miR-451 levels in patients with autism spectrum disorders. Sci. Rep. 7, 2096 (2017).","journal-title":"Sci. Rep."},{"key":"1125_CR24","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1093\/carcin\/bgr204","volume":"32","author":"G Dobbernack","year":"2011","unstructured":"Dobbernack, G. et al. Altered tissue distribution of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-DNA adducts in mice transgenic for human sulfotransferases 1A1 and 1A2. Carcinogenesis 32, 1734\u20131740 (2011).","journal-title":"Carcinogenesis"},{"key":"1125_CR25","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1093\/carcin\/bgt408","volume":"35","author":"K Herrmann","year":"2014","unstructured":"Herrmann, K. et al. Formation of hepatic DNA adducts by methyleugenol in mouse models: drastic decrease by Sult1a1 knockout and strong increase by transgenic human SULT1A1\/2. Carcinogenesis 35, 935\u2013941 (2014).","journal-title":"Carcinogenesis"},{"key":"1125_CR26","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1124\/dmd.112.045583","volume":"40","author":"KJ Rohn","year":"2012","unstructured":"Rohn, K. J., Cook, I. T., Leyh, T. S., Kadlubar, S. A. & Falany, C. N. Potent inhibition of human sulfotransferase 1A1 by 17alpha-ethinylestradiol: role of 3\u2019-phosphoadenosine 5\u2019-phosphosulfate binding and structural rearrangements in regulating inhibition and activity. Drug Metab. Dispos. 40, 1588\u20131595 (2012).","journal-title":"Drug Metab. Dispos."},{"key":"1125_CR27","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/0049-3848(87)90196-4","volume":"45","author":"H Soliman","year":"1987","unstructured":"Soliman, H. et al. Isolation of human platelets for phenolsulfotransferase activity determination: the method of choice. Thrombosis Res. 45, 279\u2013284 (1987).","journal-title":"Thrombosis Res."},{"key":"1125_CR28","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.1600-079X.2005.00246.x","volume":"39","author":"S Aust","year":"2005","unstructured":"Aust, S. et al. Biotransformation of melatonin in human breast cancer cell lines: role of sulfotransferase 1A1. J. Pineal Res. 39, 276\u2013282 (2005).","journal-title":"J. Pineal Res."},{"key":"1125_CR29","first-page":"1029","volume":"24","author":"H Soliman","year":"1986","unstructured":"Soliman, H., Callebert, J., Tabuteau, F., Mutel, V. & Dreux, C. Serum inorganic sulphate: quantitation by a new radiochemical method. J. Clin. Chem. Clin. Biochem. 24, 1029\u20131032 (1986).","journal-title":"J. Clin. Chem. Clin. Biochem."},{"key":"1125_CR30","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0009-8981(93)90029-4","volume":"221","author":"IP Kema","year":"1993","unstructured":"Kema, I. P. et al. High performance liquid chromatographic profiling of tryptophan and related indoles in body fluids and tissues of carcinoid patients. Clin. Chim. Acta 221, 143\u2013158 (1993).","journal-title":"Clin. Chim. Acta"},{"key":"1125_CR31","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/0024-3205(76)90251-4","volume":"19","author":"M Da Prada","year":"1976","unstructured":"Da Prada, M. & Zurcher, G. Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range. Life Sci. 19, 1161\u20131174 (1976).","journal-title":"Life Sci."},{"key":"1125_CR32","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/pro.3307","volume":"27","author":"PJ Thul","year":"2018","unstructured":"Thul, P. J. & Lindskog, C. The human protein atlas: A spatial map of the human proteome. Protein Sci. 27, 233\u2013244 (2018).","journal-title":"Protein Sci."},{"key":"1125_CR33","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nature19075","volume":"536","author":"X Nuttle","year":"2016","unstructured":"Nuttle, X. et al. Emergence of a Homo sapiens-specific gene family and chromosome 16p11.2 CNV susceptibility. Nature 536, 205\u2013209 (2016).","journal-title":"Nature"},{"key":"1125_CR34","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1046\/j.1523-1755.1998.00891.x","volume":"53","author":"B Hoppe","year":"1998","unstructured":"Hoppe, B., Kemper, M. J., Hvizd, M. G., Sailer, D. E. & Langman, C. B. Simultaneous determination of oxalate, citrate and sulfate in children\u2019s plasma with ion chromatography. Kidney Int. 53, 1348\u20131352 (1998).","journal-title":"Kidney Int."},{"key":"1125_CR35","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1515\/CCLM.2008.048","volume":"46","author":"KB Komosinska-Vassev","year":"2008","unstructured":"Komosinska-Vassev, K. B., Winsz-Szczotka, K., Kuznik-Trocha, K., Olczyk, P. & Olczyk, K. Age-related changes of plasma glycosaminoglycans. Clin. Chem. Lab. Med. 46, 219\u2013224 (2008).","journal-title":"Clin. Chem. Lab. Med."},{"key":"1125_CR36","doi-asserted-by":"publisher","first-page":"16315","DOI":"10.1074\/jbc.M300828200","volume":"278","author":"J Borjigin","year":"2003","unstructured":"Borjigin, J. et al. Diurnal pineal 3-O-sulphotransferase 2 expression controlled by beta-adrenergic repression. J. Biol. Chem. 278, 16315\u201316319 (2003).","journal-title":"J. Biol. Chem."},{"key":"1125_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2431-11-111","volume":"11","author":"JB Adams","year":"2011","unstructured":"Adams, J. B. et al. Effect of a vitamin\/mineral supplement on children and adults with autism. BMC Pediatrics 11, 111 (2011).","journal-title":"BMC Pediatrics"},{"key":"1125_CR38","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3390\/nu10030369","volume":"10","author":"JB Adams","year":"2018","unstructured":"Adams, J. B. et al. Comprehensive nutritional and dietary intervention for autism spectrum disorder-a randomized, controlled 12-month trial. Nutrients 10, 369 (2018).","journal-title":"Nutrients"},{"key":"1125_CR39","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1096\/fasebj.11.6.9194521","volume":"11","author":"CD Klaassen","year":"1997","unstructured":"Klaassen, C. D. & Boles, J. W. Sulfation and sulfotransferases 5: the importance of 3\u2019-phosphoadenosine 5\u2019-phosphosulfate (PAPS) in the regulation of sulfation. FASEB J. 11, 404\u2013418 (1997).","journal-title":"FASEB J."},{"key":"1125_CR40","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s11011-015-9745-2","volume":"31","author":"I Endreffy","year":"2016","unstructured":"Endreffy, I., Bjorklund, G., Dicso, F., Urbina, M. A. & Endreffy, E. Acid glycosaminoglycan (aGAG) excretion is increased in children with autism spectrum disorder, and it can be controlled by diet. Metab. Brain Dis. 31, 273\u2013278 (2016).","journal-title":"Metab. Brain Dis."},{"key":"1125_CR41","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.bbr.2011.11.004","volume":"228","author":"KZ Meyza","year":"2012","unstructured":"Meyza, K. Z., Blanchard, D. C., Pearson, B. L., Pobbe, R. L. & Blanchard, R. J. Fractone-associated N-sulfated heparan sulfate shows reduced quantity in BTBR T+tf\/J mice: a strong model of autism. Behav. Brain Res. 228, 247\u2013253 (2012).","journal-title":"Behav. Brain Res."},{"key":"1125_CR42","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1601-183X.2007.00330.x","volume":"7","author":"HG McFarlane","year":"2008","unstructured":"McFarlane, H. G. et al. Autism-like behavioral phenotypes in BTBR T+tf\/J mice. Genes Brain, Behav. 7, 152\u2013163 (2008).","journal-title":"Genes Brain, Behav."},{"key":"1125_CR43","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1601-183X.2010.00623.x","volume":"10","author":"ML Scattoni","year":"2011","unstructured":"Scattoni, M. L., Ricceri, L. & Crawley, J. N. Unusual repertoire of vocalizations in adult BTBR T+tf\/J mice during three types of social encounters. Genes, brain, Behav. 10, 44\u201356 (2011).","journal-title":"Genes, brain, Behav."},{"key":"1125_CR44","doi-asserted-by":"crossref","unstructured":"Autism Spectrum Disorders Working Group of The Psychiatric Genomics Consortium. Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia. Mol. Autism 8: 21 (2017).","DOI":"10.1186\/s13229-017-0137-9"},{"key":"1125_CR45","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41588-019-0344-8","volume":"51","author":"J Grove","year":"2019","unstructured":"Grove, J. et al. Identification of common genetic risk variants for autism spectrum disorder. Nat. Genet. 51, 431\u2013444 (2019).","journal-title":"Nat. Genet."},{"key":"1125_CR46","doi-asserted-by":"publisher","first-page":"5052","DOI":"10.1073\/pnas.1117881109","volume":"109","author":"F Irie","year":"2012","unstructured":"Irie, F., Badie-Mahdavi, H. & Yamaguchi, Y. Autism-like socio-communicative deficits and stereotypies in mice lacking heparan sulfate. Proc. Natl Acad. Sci. USA 109, 5052\u20135056 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1125_CR47","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1002\/ajmg.a.36723","volume":"164A","author":"MS Reuter","year":"2014","unstructured":"Reuter, M. S. et al. NDST1 missense mutations in autosomal recessive intellectual disability. Am. J. Med. Genet. Part A 164A, 2753\u20132763 (2014).","journal-title":"Am. J. Med. Genet. Part A"},{"key":"1125_CR48","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3389\/fgene.2019.00574","volume":"10","author":"KA Hope","year":"2019","unstructured":"Hope, K. A. et al. The Drosophila gene sulfateless modulates autism-like behaviors. Front. Genet. 10, 574 (2019).","journal-title":"Front. Genet."},{"key":"1125_CR49","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nature07999","volume":"459","author":"K Wang","year":"2009","unstructured":"Wang, K. et al. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 459, 528\u2013533 (2009).","journal-title":"Nature"},{"key":"1125_CR50","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nature09146","volume":"466","author":"D Pinto","year":"2010","unstructured":"Pinto, D. et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 466, 368\u2013372 (2010).","journal-title":"Nature"},{"key":"1125_CR51","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1038\/nature05817","volume":"446","author":"JR Bishop","year":"2007","unstructured":"Bishop, J. R., Schuksz, M. & Esko, J. D. Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 446, 1030\u20131037 (2007).","journal-title":"Nature"},{"key":"1125_CR52","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/j.cell.2018.07.002","volume":"174","author":"P Zhang","year":"2018","unstructured":"Zhang, P. et al. Heparan sulfate organizes neuronal synapses through neurexin partnerships. Cell 174, 1450\u20131464 e1423 (2018).","journal-title":"Cell"},{"key":"1125_CR53","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nm.3193","volume":"19","author":"R Delorme","year":"2013","unstructured":"Delorme, R. et al. Progress toward treatments for synaptic defects in autism. Nat. Med. 19, 685\u2013694 (2013).","journal-title":"Nat. Med."},{"key":"1125_CR54","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.mam.2016.07.001","volume":"51","author":"CA Dwyer","year":"2016","unstructured":"Dwyer, C. A. & Esko, J. D. Glycan susceptibility factors in autism spectrum disorders. Mol. Asp. Med. 51, 104\u2013114 (2016).","journal-title":"Mol. Asp. Med."},{"key":"1125_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s13064-016-0066-x","volume":"11","author":"C Perez","year":"2016","unstructured":"Perez, C., Sawmiller, D. & Tan, J. The role of heparan sulfate deficiency in autistic phenotype: potential involvement of Slit\/Robo\/srGAPs-mediated dendritic spine formation. Neural Dev. 11, 11 (2016).","journal-title":"Neural Dev."},{"key":"1125_CR56","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ijdevneu.2004.08.002","volume":"23","author":"SR Chandana","year":"2005","unstructured":"Chandana, S. R. et al. Significance of abnormalities in developmental trajectory and asymmetry of cortical serotonin synthesis in autism. Int. J. Developmental Neurosci. 23, 171\u2013182 (2005).","journal-title":"Int. J. Developmental Neurosci."},{"key":"1125_CR57","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.phrs.2018.07.010","volume":"140","author":"VR Garbarino","year":"2019","unstructured":"Garbarino, V. R., Gilman, T. L., Daws, L. C. & Gould, G. G. Extreme enhancement or depletion of serotonin transporter function and serotonin availability in autism spectrum disorder. Pharmacol. Res. 140, 85\u201399 (2019).","journal-title":"Pharmacol. Res."},{"key":"1125_CR58","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1007\/s00702-018-1927-8","volume":"125","author":"JC Shih","year":"2018","unstructured":"Shih, J. C. Monoamine oxidase isoenzymes: genes, functions and targets for behavior and cancer therapy. J. Neural Transm. (Vienna) 125, 1553\u20131566 (2018).","journal-title":"J. Neural Transm. (Vienna)"},{"key":"1125_CR59","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1002\/jnr.24027","volume":"95","author":"F Gu","year":"2017","unstructured":"Gu, F., Chauhan, V. & Chauhan, A. Monoamine oxidase-A and B activities in the cerebellum and frontal cortex of children and young adults with autism. J. Neurosci. Res. 95, 1965\u20131972 (2017).","journal-title":"J. Neurosci. Res."},{"key":"1125_CR60","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/07435808509032980","volume":"11","author":"O Kuchel","year":"1985","unstructured":"Kuchel, O., Buu, N. T. & Neemeh, J. The platelet phenolsulfotransferase is not indispensable for the sulfoconjugation of plasma catecholamines. Endocr. Res. 11, 225\u2013232 (1985).","journal-title":"Endocr. Res."},{"key":"1125_CR61","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1001\/archpsyc.1977.01770170063005","volume":"34","author":"CR Lake","year":"1977","unstructured":"Lake, C. R., Ziegler, M. G. & Murphy, D. L. Increased norepinephrine levels and decreased dopamine-beta-hydroxylase activity in primary autism. Arch. Gen. Psychiatry 34, 553\u2013556 (1977).","journal-title":"Arch. Gen. Psychiatry"},{"key":"1125_CR62","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/BF01487064","volume":"17","author":"JM Launay","year":"1987","unstructured":"Launay, J. M. et al. Catecholamines metabolism in infantile autism: a controlled study of 22 autistic children. J. Autism Dev. Disord. 17, 333\u2013347 (1987).","journal-title":"J. Autism Dev. Disord."},{"key":"1125_CR63","first-page":"2734","volume":"86","author":"K Richard","year":"2001","unstructured":"Richard, K. et al. Sulfation of thyroid hormone and dopamine during human development: ontogeny of phenol sulfotransferases and arylsulfatase in liver, lung, and brain. J. Clin. Endocrinol. Metab. 86, 2734\u20132742 (2001).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1125_CR64","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1124\/dmd.108.025767","volume":"37","author":"ED Salman","year":"2009","unstructured":"Salman, E. D., Kadlubar, S. A. & Falany, C. N. Expression and localization of cytosolic sulfotransferase (SULT) 1A1 and SULT1A3 in normal human brain. Drug Metab. Dispos. 37, 706\u2013709 (2009).","journal-title":"Drug Metab. Dispos."},{"key":"1125_CR65","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000184710","volume":"123","author":"SJ Hebbring","year":"2008","unstructured":"Hebbring, S. J., Moyer, A. M. & Weinshilboum, R. M. Sulfotransferase gene copy number variation: pharmacogenetics and function. Cytogenetic Genome Res. 123, 205\u2013210 (2008).","journal-title":"Cytogenetic Genome Res."},{"key":"1125_CR66","first-page":"19","volume":"6","author":"X Yu","year":"2013","unstructured":"Yu, X. et al. Copy number variation in sulfotransferase isoform 1A1 (SULT1A1) is significantly associated with enzymatic activity in Japanese subjects. Pharmacogenomics personalized Med. 6, 19\u201324 (2013).","journal-title":"Pharmacogenomics personalized Med."},{"key":"1125_CR67","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jsbmb.2017.08.017","volume":"174","author":"J Liu","year":"2017","unstructured":"Liu, J. et al. Relationship of SULT1A1 copy number variation with estrogen metabolism and human health. J. Steroid Biochem. Mol. Biol. 174, 169\u2013175 (2017).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"1125_CR68","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S0006-3223(98)00337-0","volume":"46","author":"A Alberti","year":"1999","unstructured":"Alberti, A., Pirrone, P., Elia, M., Waring, R. H. & Romano, C. Sulphation deficit in \u201clow-functioning\u201d autistic children: a pilot study. Biol. Psychiatry 46, 420\u2013424 (1999).","journal-title":"Biol. Psychiatry"},{"key":"1125_CR69","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1159\/000480563","volume":"16","author":"M Cappiello","year":"1991","unstructured":"Cappiello, M., Giuliani, L., Rane, A. & Pacifici, G. M. Dopamine sulphotransferase is better developed than p-nitrophenol sulphotransferase in the human fetus. Dev. Pharmacol. Ther. 16, 83\u201388 (1991).","journal-title":"Dev. Pharmacol. Ther."},{"key":"1125_CR70","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1139\/y81-047","volume":"59","author":"L Abenhaim","year":"1981","unstructured":"Abenhaim, L., Romain, Y. & Kuchel, O. Platelet phenolsulfotransferase and catecholamines: physiological and pathological variations in humans. Can. J. Physiol. Pharmacol. 59, 300\u2013306 (1981).","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"1125_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000026509","volume":"38","author":"D Marazziti","year":"1998","unstructured":"Marazziti, D., Palego, L., Rossi, A. & Cassano, G. B. Gender-related seasonality of human platelet phenolsulfotransferase activity. Neuropsychobiology 38, 1\u20135 (1998).","journal-title":"Neuropsychobiology"},{"key":"1125_CR72","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1097\/00008571-200012000-00004","volume":"10","author":"S Nowell","year":"2000","unstructured":"Nowell, S. et al. Relationship of phenol sulfotransferase activity (SULT1A1) genotype to sulfotransferase phenotype in platelet cytosol. Pharmacogenetics 10, 789\u2013797 (2000).","journal-title":"Pharmacogenetics"},{"key":"1125_CR73","first-page":"773","volume":"112","author":"RJ Anderson","year":"1988","unstructured":"Anderson, R. J., Jackson, B. L. & Liebentritt, D. K. Human platelet thermostable phenol sulfotransferase from blacks and whites: biochemical properties and variations in thermal stability. J. Lab. Clin. Med. 112, 773\u2013783 (1988).","journal-title":"J. Lab. Clin. Med."},{"key":"1125_CR74","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1158\/1055-9965.EPI-03-0047","volume":"13","author":"S Nowell","year":"2004","unstructured":"Nowell, S. et al. Association of SULT1A1 phenotype and genotype with prostate cancer risk in African-Americans and Caucasians. Cancer Epidemiol., Biomark. Prev. 13, 270\u2013276 (2004).","journal-title":"Cancer Epidemiol., Biomark. Prev."},{"key":"1125_CR75","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0014-5793(01)02129-9","volume":"490","author":"EV Petrotchenko","year":"2001","unstructured":"Petrotchenko, E. V., Pedersen, L. C., Borchers, C. H., Tomer, K. B. & Negishi, M. The dimerization motif of cytosolic sulfotransferases. FEBS Lett. 490, 39\u201343 (2001).","journal-title":"FEBS Lett."},{"key":"1125_CR76","doi-asserted-by":"publisher","first-page":"20305","DOI":"10.1074\/jbc.M117.817387","volume":"292","author":"T Wang","year":"2017","unstructured":"Wang, T., Cook, I. & Leyh, T. S. The NSAID allosteric site of human cytosolic sulfotransferases. J. Biol. Chem. 292, 20305\u201320312 (2017).","journal-title":"J. Biol. Chem."},{"key":"1125_CR77","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1074\/jbc.RA118.006511","volume":"294","author":"K Darrah","year":"2019","unstructured":"Darrah, K. et al. Allosteres to regulate neurotransmitter sulfonation. J. Biol. Chem. 294, 2293\u20132301 (2019).","journal-title":"J. Biol. Chem."},{"key":"1125_CR78","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.biopsych.2004.11.003","volume":"57","author":"S Tordjman","year":"2005","unstructured":"Tordjman, S., Anderson, G. M., Pichard, N., Charbuy, H. & Touitou, Y. Nocturnal excretion of 6-sulphatoxymelatonin in children and adolescents with autistic disorder. Biol. Psychiatry 57, 134\u2013138 (2005).","journal-title":"Biol. Psychiatry"},{"key":"1125_CR79","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000258640","volume":"61","author":"EJ Mulder","year":"2010","unstructured":"Mulder, E. J. et al. Urinary excretion of 5-hydroxyindoleacetic acid, serotonin and 6-sulphatoxymelatonin in normoserotonemic and hyperserotonemic autistic individuals. Neuropsychobiology 61, 27\u201332 (2010).","journal-title":"Neuropsychobiology"},{"key":"1125_CR80","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3109\/00498254.2015.1107656","volume":"46","author":"L Luo","year":"2016","unstructured":"Luo, L. et al. Sulfation of 6-hydroxymelatonin, N-acetylserotonin and 4-hydroxyramelteon by the human cytosolic sulfotransferases (SULTs). Xenobiotica 46, 612\u2013619 (2016).","journal-title":"Xenobiotica"},{"key":"1125_CR81","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/toxsci\/kfj061","volume":"90","author":"N Gamage","year":"2006","unstructured":"Gamage, N. et al. Human sulfotransferases and their role in chemical metabolism. Toxicological Sci. 90, 5\u201322 (2006).","journal-title":"Toxicological Sci."},{"key":"1125_CR82","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.neuint.2016.10.011","volume":"101","author":"CJ Carter","year":"2016","unstructured":"Carter, C. J. & Blizard, R. A. Autism genes are selectively targeted by environmental polluants including pesticides, heavy metals, bisphenol A, phtalates and many others in food, cosmetics or household products. Neurochemistry Int. 101, 83\u2013109 (2016).","journal-title":"Neurochemistry Int."},{"key":"1125_CR83","doi-asserted-by":"publisher","first-page":"46001","DOI":"10.1289\/EHP4386","volume":"127","author":"KE Pelch","year":"2019","unstructured":"Pelch, K. E., Bolden, A. L. & Kwiatkowski, C. F. Environmental Chemicals and Autism: A Scoping Review of the Human and Animal Research. Environ. Health Perspect. 127, 46001 (2019).","journal-title":"Environ. Health Perspect."},{"key":"1125_CR84","doi-asserted-by":"publisher","first-page":"4139","DOI":"10.1021\/jf035339u","volume":"52","author":"CT Yeh","year":"2004","unstructured":"Yeh, C. T., Shih, P. H. & Yen, G. C. Synergistic effect of antioxidant phenolic acids on human phenolsulfotransferase activity. J. Agric. Food Chem. 52, 4139\u20134143 (2004).","journal-title":"J. Agric. Food Chem."},{"key":"1125_CR85","doi-asserted-by":"publisher","first-page":"5469","DOI":"10.1073\/pnas.1112345109","volume":"109","author":"J Veenstra-VanderWeele","year":"2012","unstructured":"Veenstra-VanderWeele, J. et al. Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior. Proc. Natl Acad. Sci. USA 109, 5469\u20135474 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1125_CR86","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1093\/hmg\/ddy421","volume":"28","author":"S Gabriele","year":"2019","unstructured":"Gabriele, S. et al. Evidence that ITGB3 promoter variants increase serotonin blood levels by regulating platelet serotonin transporter trafficking. Hum. Mol. Genet. 28, 1153\u20131161 (2019).","journal-title":"Hum. Mol. Genet."},{"key":"1125_CR87","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1172\/JCI33374","volume":"118","author":"AM Carneiro","year":"2008","unstructured":"Carneiro, A. M., Cook, E. H., Murphy, D. L. & Blakely, R. D. Interactions between integrin alphaIIbbeta3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans. J. Clin. Investig. 118, 1544\u20131552 (2008).","journal-title":"J. Clin. Investig."},{"key":"1125_CR88","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-018-0243-3","volume":"9","author":"M Tanaka","year":"2018","unstructured":"Tanaka, M. et al. Brain hyperserotonemia causes autism-relevant social deficits in mice. Mol. autism 9, 60 (2018).","journal-title":"Mol. autism"},{"key":"1125_CR89","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0048975","volume":"7","author":"MJ Kane","year":"2012","unstructured":"Kane, M. J. et al. Mice genetically depleted of brain serotonin display social impairments, communication deficits and repetitive behaviors: possible relevance to autism. PloS ONE 7, e48975 (2012).","journal-title":"PloS ONE"},{"key":"1125_CR90","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s41586-019-1024-7","volume":"567","author":"LA Farrelly","year":"2019","unstructured":"Farrelly, L. A. et al. Histone serotonylation is a permissive modification that enhances TFIID binding to H3K4me3. Nature 567, 535\u2013539 (2019).","journal-title":"Nature"},{"key":"1125_CR91","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41593-018-0295-x","volume":"22","author":"ST Schafer","year":"2019","unstructured":"Schafer, S. T. et al. Pathological priming causes developmental gene network heterochronicity in autistic subject-derived neurons. Nat. Neurosci. 22, 243\u2013255 (2019).","journal-title":"Nat. Neurosci."}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-020-01125-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-020-01125-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-020-01125-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T15:14:30Z","timestamp":1669821270000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-020-01125-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["1125"],"URL":"https:\/\/doi.org\/10.1038\/s41398-020-01125-5","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,7]]},"assertion":[{"value":"16 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"23"}}